Ga onbeperkt met Magzter GOLD

Ga onbeperkt met Magzter GOLD

Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts

$149.99
 
$74.99/Jaar

Poging GOUD - Vrij

Carmakers rev up plans to follow fuel efficiency norms

Mint Mumbai

|

October 08, 2025

Maruti, Mahindra, Hyundai, Tata Motors are all looking to increase sales of green vehicles

- Ayaan Kartik & Nehal Chaliawala

Carmakers rev up plans to follow fuel efficiency norms

The CAFE 3 norms mandate carmakers to gradually cut average fuel consumption of the cars they sell from 3.73 litres per 100km in 2027 to 3.01 litres by 2032.

(REUTERS)

Maruti Suzuki India Ltd, Mahindra & Mahindra Ltd (M&M) and Hyundai Motor India Ltd will have to ramp up the share of electric, CNG and hybrid vehicles in their sales to comply with stricter fuel efficiency rules to be rolled out from April 2027 in India.

Maruti Suzuki, India's largest carmaker, and Mahindra seek to bump the share of electric vehicles (EVs) to nearly a fifth of their sales in the coming years from below 5% in the year ended March 2025, according to plans disclosed by companies. Tata Motors, with a third of its sales coming from CNG and electric cars last fiscal, is relatively better placed than peers to meet the Corporate Average Fuel Efficiency (CAFE) 3 norms.

The target will be relatively tougher to meet for Mahindra and Hyundai, whose portfolios are dominated by big sport utility vehicles (SUVs), according to a Goldman Sachs report. Tata Motors will be able to meet emission norms cap, it said.

MEER VERHALEN VAN Mint Mumbai

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size